BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 20595275)

  • 1. Treatment approaches to juvenile dermatomyositis (JDM) across North America: The Childhood Arthritis and Rheumatology Research Alliance (CARRA) JDM Treatment Survey.
    Stringer E; Bohnsack J; Bowyer SL; Griffin TA; Huber AM; Lang B; Lindsley CB; Ota S; Pilkington C; Reed AM; Scuccimarri R; Feldman BM
    J Rheumatol; 2010 Sep; 37(9):1953-61. PubMed ID: 20595275
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biologic therapies for refractory juvenile dermatomyositis: five years of experience of the Childhood Arthritis and Rheumatology Research Alliance in North America.
    Spencer CH; Rouster-Stevens K; Gewanter H; Syverson G; Modica R; Schmidt K; Emery H; Wallace C; Grevich S; Nanda K; Zhao YD; Shenoi S; Tarvin S; Hong S; Lindsley C; Weiss JE; Passo M; Ede K; Brown A; Ardalan K; Bernal W; Stoll ML; Lang B; Carrasco R; Agaiar C; Feller L; Bukulmez H; Vehe R; Kim H; Schmeling H; Gerstbacher D; Hoeltzel M; Eberhard B; Sundel R; Kim S; Huber AM; Patwardhan A;
    Pediatr Rheumatol Online J; 2017 Jun; 15(1):50. PubMed ID: 28610606
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Childhood Arthritis and Rheumatology Research Alliance Consensus Clinical Treatment Plans for Juvenile Dermatomyositis with Persistent Skin Rash.
    Huber AM; Kim S; Reed AM; Carrasco R; Feldman BM; Hong SD; Kahn P; Rahimi H; Robinson AB; Vehe RK; Weiss JE; Spencer C;
    J Rheumatol; 2017 Jan; 44(1):110-116. PubMed ID: 27803135
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of pediatric localized scleroderma: results of a survey of North American pediatric rheumatologists.
    Li SC; Feldman BM; Higgins GC; Haines KA; Punaro MG; O'Neil KM
    J Rheumatol; 2010 Jan; 37(1):175-81. PubMed ID: 19918041
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment escalation patterns to start biologics in refractory moderate juvenile dermatomyositis among members of the Childhood Arthritis and Rheumatology Research Alliance.
    Sherman MA; Kim H; Banschbach K; Brown A; Gewanter HL; Lang B; Perron M; Robinson AB; Spitznagle J; Stingl C; Syverson G; Tory HO; Spencer CH; Tarvin SE
    Pediatr Rheumatol Online J; 2023 Jan; 21(1):3. PubMed ID: 36609397
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current management of juvenile dermatomyositis in Germany and Austria: an online survey of pediatric rheumatologists and pediatric neurologists.
    Hinze CH; Speth F; Oommen PT; Haas JP
    Pediatr Rheumatol Online J; 2018 Jun; 16(1):38. PubMed ID: 29925381
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intravenous immunoglobulin therapy for juvenile dermatomyositis: efficacy and safety.
    Al-Mayouf SM; Laxer RM; Schneider R; Silverman ED; Feldman BM
    J Rheumatol; 2000 Oct; 27(10):2498-503. PubMed ID: 11036850
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic approaches in the treatment of juvenile dermatomyositis in patients with recent-onset disease and in those experiencing disease flare: an international multicenter PRINTO study.
    Hasija R; Pistorio A; Ravelli A; Demirkaya E; Khubchandani R; Guseinova D; Malattia C; Canhao H; Harel L; Foell D; Wouters C; De Cunto C; Huemer C; Kimura Y; Mangge H; Minetti C; Nordal EB; Philippet P; Garozzo R; Martini A; Ruperto N;
    Arthritis Rheum; 2011 Oct; 63(10):3142-52. PubMed ID: 21647864
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Juvenile dermatomyositis: advances in clinical presentation, myositis-specific antibodies and treatment.
    Wu JQ; Lu MP; Reed AM
    World J Pediatr; 2020 Feb; 16(1):31-43. PubMed ID: 31556011
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Physician practices for withdrawal of medications in inactive systemic juvenile arthritis, Childhood Arthritis and Rheumatology Research Alliance (CARRA) survey.
    Shenoi S; Nanda K; Schulert GS; Bohnsack JF; Cooper AM; Edghill B; Gillispie-Taylor MC; Goldberg B; Halyabar O; Mason TG; Ronis T; Schneider R; Vehe RK; Onel K;
    Pediatr Rheumatol Online J; 2019 Jul; 17(1):48. PubMed ID: 31331351
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Juvenile dermatomyositis in north India.
    Singh S; Kumar L; Shankar KR
    Indian Pediatr; 1997 Mar; 34(3):193-8. PubMed ID: 9282485
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Juvenile dermatomyositis with a rare and remarkable complication: sinus bradycardia.
    Karaca NE; Aksu G; Yeniay BS; Kutukculer N
    Rheumatol Int; 2006 Dec; 27(2):179-82. PubMed ID: 16944159
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Childhood Arthritis and Rheumatology Research Alliance consensus clinical treatment plans for juvenile dermatomyositis with skin predominant disease.
    Kim S; Kahn P; Robinson AB; Lang B; Shulman A; Oberle EJ; Schikler K; Curran ML; Barillas-Arias L; Spencer CH; Rider LG; Huber AM
    Pediatr Rheumatol Online J; 2017 Jan; 15(1):1. PubMed ID: 28077146
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intravenous cyclophosphamide pulse therapy in juvenile dermatomyositis. A review of efficacy and safety.
    Riley P; Maillard SM; Wedderburn LR; Woo P; Murray KJ; Pilkington CA
    Rheumatology (Oxford); 2004 Apr; 43(4):491-6. PubMed ID: 14722349
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment, classification and treatment of calcinosis as a complication of juvenile dermatomyositis: a survey of pediatric rheumatologists by the childhood arthritis and rheumatology research alliance (CARRA).
    Orandi AB; Baszis KW; Dharnidharka VR; Huber AM; Hoeltzel MF;
    Pediatr Rheumatol Online J; 2017 Sep; 15(1):71. PubMed ID: 28934971
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of polymyositis and dermatomyositis.
    Kaye SA; Isenberg DA
    Br J Hosp Med; 1994 Nov 2-15; 52(9):463-8. PubMed ID: 7874361
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Juvenile dermatomyositis: diagnosis and treatment].
    Gissinger-Prévot S; Figarella-Branger D; Mancini J; Chabrol B
    Arch Pediatr; 2008 Jan; 15(1):50-3. PubMed ID: 18164188
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of practice and consensus-based strategies including a treat-to-target approach for the management of moderate and severe juvenile dermatomyositis in Germany and Austria.
    Hinze CH; Oommen PT; Dressler F; Urban A; Weller-Heinemann F; Speth F; Lainka E; Brunner J; Fesq H; Foell D; Müller-Felber W; Neudorf U; Rietschel C; Schwarz T; Schara U; Haas JP
    Pediatr Rheumatol Online J; 2018 Jun; 16(1):40. PubMed ID: 29940960
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Juvenile idiopathic arthritis.
    Boros C; Whitehead B
    Aust Fam Physician; 2010 Sep; 39(9):630-6. PubMed ID: 20877765
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Juvenile dermatomyositis at a tertiary care hospital: is there any change in the last decade?
    Prasad S; Misra R; Agarwal V; Lawrence A; Aggarwal A
    Int J Rheum Dis; 2013 Oct; 16(5):556-60. PubMed ID: 24164843
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.